2025-01-01 2025-12-31 2025-12-31 false 09903467 OXFORD MEDICAL DEVICES LIMITED 2026-03-16 74909 false iso4217:GBP xbrli:pure 09903467 2024-12-31 09903467 2025-12-31 09903467 2025-01-01 2025-12-31 09903467 2023-12-31 09903467 2024-12-31 09903467 2024-01-01 2024-12-31 09903467 bus:SmallEntities 2025-01-01 2025-12-31 09903467 bus:AuditExempt-NoAccountantsReport 2025-01-01 2025-12-31 09903467 bus:AbridgedAccounts 2025-01-01 2025-12-31 09903467 bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 09903467 core:WithinOneYear 2025-12-31 09903467 core:AfterOneYear 2025-12-31 09903467 core:WithinOneYear 2024-12-31 09903467 core:AfterOneYear 2024-12-31 09903467 core:ShareCapital 2025-12-31 09903467 core:SharePremium 2025-12-31 09903467 core:RevaluationReserve 2025-12-31 09903467 core:OtherReservesSubtotal 2025-12-31 09903467 core:RetainedEarningsAccumulatedLosses 2025-12-31 09903467 core:ShareCapital 2024-12-31 09903467 core:SharePremium 2024-12-31 09903467 core:RevaluationReserve 2024-12-31 09903467 core:OtherReservesSubtotal 2024-12-31 09903467 core:RetainedEarningsAccumulatedLosses 2024-12-31 09903467 core:LandBuildings 2025-12-31 09903467 core:PlantMachinery 2025-12-31 09903467 core:Vehicles 2025-12-31 09903467 core:FurnitureFittings 2025-12-31 09903467 core:OfficeEquipment 2025-12-31 09903467 core:NetGoodwill 2025-12-31 09903467 core:IntangibleAssetsOtherThanGoodwill 2025-12-31 09903467 core:ListedExchangeTraded 2025-12-31 09903467 core:UnlistedNon-exchangeTraded 2025-12-31 09903467 core:LandBuildings 2024-12-31 09903467 core:PlantMachinery 2024-12-31 09903467 core:Vehicles 2024-12-31 09903467 core:FurnitureFittings 2024-12-31 09903467 core:OfficeEquipment 2024-12-31 09903467 core:NetGoodwill 2024-12-31 09903467 core:IntangibleAssetsOtherThanGoodwill 2024-12-31 09903467 core:ListedExchangeTraded 2024-12-31 09903467 core:UnlistedNon-exchangeTraded 2024-12-31 09903467 core:LandBuildings 2025-01-01 2025-12-31 09903467 core:PlantMachinery 2025-01-01 2025-12-31 09903467 core:Vehicles 2025-01-01 2025-12-31 09903467 core:FurnitureFittings 2025-01-01 2025-12-31 09903467 core:OfficeEquipment 2025-01-01 2025-12-31 09903467 core:NetGoodwill 2025-01-01 2025-12-31 09903467 core:IntangibleAssetsOtherThanGoodwill 2025-01-01 2025-12-31 09903467 core:ListedExchangeTraded 2025-01-01 2025-12-31 09903467 core:UnlistedNon-exchangeTraded 2025-01-01 2025-12-31 09903467 core:MoreThanFiveYears 2025-01-01 2025-12-31 09903467 core:Non-currentFinancialInstruments 2025-12-31 09903467 core:Non-currentFinancialInstruments 2024-12-31 09903467 dpl:CostSales 2025-01-01 2025-12-31 09903467 dpl:DistributionCosts 2025-01-01 2025-12-31 09903467 core:LandBuildings 2025-01-01 2025-12-31 09903467 core:PlantMachinery 2025-01-01 2025-12-31 09903467 core:Vehicles 2025-01-01 2025-12-31 09903467 core:FurnitureFittings 2025-01-01 2025-12-31 09903467 core:OfficeEquipment 2025-01-01 2025-12-31 09903467 dpl:AdministrativeExpenses 2025-01-01 2025-12-31 09903467 core:NetGoodwill 2025-01-01 2025-12-31 09903467 core:IntangibleAssetsOtherThanGoodwill 2025-01-01 2025-12-31 09903467 dpl:GroupUndertakings 2025-01-01 2025-12-31 09903467 dpl:ParticipatingInterests 2025-01-01 2025-12-31 09903467 dpl:GroupUndertakings core:ListedExchangeTraded 2025-01-01 2025-12-31 09903467 core:ListedExchangeTraded 2025-01-01 2025-12-31 09903467 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2025-01-01 2025-12-31 09903467 core:UnlistedNon-exchangeTraded 2025-01-01 2025-12-31 09903467 dpl:CostSales 2024-01-01 2024-12-31 09903467 dpl:DistributionCosts 2024-01-01 2024-12-31 09903467 core:LandBuildings 2024-01-01 2024-12-31 09903467 core:PlantMachinery 2024-01-01 2024-12-31 09903467 core:Vehicles 2024-01-01 2024-12-31 09903467 core:FurnitureFittings 2024-01-01 2024-12-31 09903467 core:OfficeEquipment 2024-01-01 2024-12-31 09903467 dpl:AdministrativeExpenses 2024-01-01 2024-12-31 09903467 core:NetGoodwill 2024-01-01 2024-12-31 09903467 core:IntangibleAssetsOtherThanGoodwill 2024-01-01 2024-12-31 09903467 dpl:GroupUndertakings 2024-01-01 2024-12-31 09903467 dpl:ParticipatingInterests 2024-01-01 2024-12-31 09903467 dpl:GroupUndertakings core:ListedExchangeTraded 2024-01-01 2024-12-31 09903467 core:ListedExchangeTraded 2024-01-01 2024-12-31 09903467 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2024-01-01 2024-12-31 09903467 core:UnlistedNon-exchangeTraded 2024-01-01 2024-12-31 09903467 core:NetGoodwill 2025-12-31 09903467 core:IntangibleAssetsOtherThanGoodwill 2025-12-31 09903467 core:LandBuildings 2025-12-31 09903467 core:PlantMachinery 2025-12-31 09903467 core:Vehicles 2025-12-31 09903467 core:FurnitureFittings 2025-12-31 09903467 core:OfficeEquipment 2025-12-31 09903467 core:AfterOneYear 2025-12-31 09903467 core:WithinOneYear 2025-12-31 09903467 core:ListedExchangeTraded 2025-12-31 09903467 core:UnlistedNon-exchangeTraded 2025-12-31 09903467 core:ShareCapital 2025-12-31 09903467 core:SharePremium 2025-12-31 09903467 core:RevaluationReserve 2025-12-31 09903467 core:OtherReservesSubtotal 2025-12-31 09903467 core:RetainedEarningsAccumulatedLosses 2025-12-31 09903467 core:NetGoodwill 2024-12-31 09903467 core:IntangibleAssetsOtherThanGoodwill 2024-12-31 09903467 core:LandBuildings 2024-12-31 09903467 core:PlantMachinery 2024-12-31 09903467 core:Vehicles 2024-12-31 09903467 core:FurnitureFittings 2024-12-31 09903467 core:OfficeEquipment 2024-12-31 09903467 core:AfterOneYear 2024-12-31 09903467 core:WithinOneYear 2024-12-31 09903467 core:ListedExchangeTraded 2024-12-31 09903467 core:UnlistedNon-exchangeTraded 2024-12-31 09903467 core:ShareCapital 2024-12-31 09903467 core:SharePremium 2024-12-31 09903467 core:RevaluationReserve 2024-12-31 09903467 core:OtherReservesSubtotal 2024-12-31 09903467 core:RetainedEarningsAccumulatedLosses 2024-12-31 09903467 core:NetGoodwill 2023-12-31 09903467 core:IntangibleAssetsOtherThanGoodwill 2023-12-31 09903467 core:LandBuildings 2023-12-31 09903467 core:PlantMachinery 2023-12-31 09903467 core:Vehicles 2023-12-31 09903467 core:FurnitureFittings 2023-12-31 09903467 core:OfficeEquipment 2023-12-31 09903467 core:AfterOneYear 2023-12-31 09903467 core:WithinOneYear 2023-12-31 09903467 core:ListedExchangeTraded 2023-12-31 09903467 core:UnlistedNon-exchangeTraded 2023-12-31 09903467 core:ShareCapital 2023-12-31 09903467 core:SharePremium 2023-12-31 09903467 core:RevaluationReserve 2023-12-31 09903467 core:OtherReservesSubtotal 2023-12-31 09903467 core:RetainedEarningsAccumulatedLosses 2023-12-31 09903467 core:AfterOneYear 2025-01-01 2025-12-31 09903467 core:WithinOneYear 2025-01-01 2025-12-31 09903467 core:Non-currentFinancialInstruments core:CostValuation 2025-01-01 2025-12-31 09903467 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2025-01-01 2025-12-31 09903467 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2025-01-01 2025-12-31 09903467 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2025-01-01 2025-12-31 09903467 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2025-01-01 2025-12-31 09903467 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2025-01-01 2025-12-31 09903467 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2025-01-01 2025-12-31 09903467 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2025-01-01 2025-12-31 09903467 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2025-01-01 2025-12-31 09903467 core:Non-currentFinancialInstruments core:CostValuation 2025-12-31 09903467 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2025-12-31 09903467 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2025-12-31 09903467 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2025-12-31 09903467 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2025-12-31 09903467 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2025-12-31 09903467 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2025-12-31 09903467 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2025-12-31 09903467 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2025-12-31 09903467 core:Non-currentFinancialInstruments core:CostValuation 2024-12-31 09903467 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2024-12-31 09903467 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2024-12-31 09903467 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2024-12-31 09903467 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2024-12-31 09903467 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2024-12-31 09903467 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2024-12-31 09903467 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2024-12-31 09903467 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2024-12-31 09903467 bus:Director1 2025-01-01 2025-12-31 09903467 bus:Director2 2025-01-01 2025-12-31

OXFORD MEDICAL DEVICES LIMITED

Registered Number
09903467
(England and Wales)

Unaudited Financial Statements for the Year ended
31 December 2025

OXFORD MEDICAL DEVICES LIMITED
Company Information
for the year from 1 January 2025 to 31 December 2025

Directors | GOULD, Magdalena Katarzyna
| GOULD, Marcus, Dr

Registered Address | Unit 1, Pearl Assurance House
| Elbow Lane
| Tavistock
| PL19 0BG

Registered Number | 09903467 (England and Wales)

OXFORD MEDICAL DEVICES LIMITED
Balance Sheet as at
31 December 2025

| Notes | 2025 |  | 2024
--- | --- | --- | --- | ---
|  | £ |  | £ |  | £ |  | £
Fixed assets |  |  |  |  |  |  |  |
Tangible assets | 3 |  |  | 1,478 |  |  |  | 2,403
|  |  |  | 1,478 |  |  |  | 2,403
Current assets |  |  |  |  |  |  |  |
Debtors |  | 17,649 |  |  |  | 25,842 |  |
Cash at bank and on hand |  | 285,111 |  |  |  | 235,088 |  |
|  | 302,760 |  |  |  | 260,930 |  |
Creditors amounts falling due within one year | 4 | (27,868) |  |  |  | (37,602) |  |
Net current assets (liabilities) |  |  |  | 274,892 |  |  |  | 223,328
Total assets less current liabilities |  |  |  | 276,370 |  |  |  | 225,731
Net assets |  |  |  | 276,370 |  |  |  | 225,731
Capital and reserves |  |  |  |  |  |  |  |
Called up share capital |  |  |  | 12 |  |  |  | 12
Profit and loss account |  |  |  | 276,358 |  |  |  | 225,719
Shareholders' funds |  |  |  | 276,370 |  |  |  | 225,731

- The company was entitled to exemption from audit for this reporting period under section 477 of the Companies Act 2006 relating to small companies.
- The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
- The Directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
- These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
- The directors have chosen to not file a copy of the company’s profit and loss account under section 444 (5A) Companies Act 2006.
- The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).

The financial statements were approved and authorised for issue by the Board of Directors on 16 March 2026, and are signed on its behalf by:
GOULD, Magdalena Katarzyna Director
GOULD, Marcus, Dr Director Registered Company No. 09903467

OXFORD MEDICAL DEVICES LIMITED
Notes to the Financial Statements
for the year ended 31 December 2025

1. | Accounting policies
--- | ---

| Statutory information
--- | ---
| The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

| Statement of compliance
--- | ---
| The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.

| Revenue from sale of goods
--- | ---
| Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.

| Employee benefits
--- | ---
| Contributions to defined contribution plans are expensed in the period to which they relate.

| Foreign currency translation
--- | ---
| Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.

| Tangible fixed assets and depreciation
--- | ---
| Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

2. | Average number of employees
--- | ---

|  | 2025 |  | 2024
| Average number of employees during the year | 2 |  | 2

3. | Tangible fixed assets
--- | ---

|  | Total
--- | --- | ---
|  | £
| Cost or valuation
| At 01 January 25 | 7,842
| Additions | 738
| At 31 December 25 | 8,580
| Depreciation and impairment
| At 01 January 25 | 5,438
| Charge for year | 1,664
| At 31 December 25 | 7,102
| Net book value
| At 31 December 25 | 1,478
| At 31 December 24 | 2,403

4. | Creditors: amounts due within one year
--- | ---

|  | 2025 |  | 2024
--- | --- | --- | --- | ---
|  | £ |  | £
| Taxation and social security | 27,174 |  | 36,479
| Other creditors | - |  | 463
| Accrued liabilities and deferred income | 694 |  | 660
| Total | 27,868 |  | 37,602

| Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.